161 related articles for article (PubMed ID: 11840039)
21. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer.
Javid G; Masoodi I; Zargar SA; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS
Am J Med; 2001 Sep; 111(4):280-4. PubMed ID: 11566458
[TBL] [Abstract][Full Text] [Related]
22. Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.
Hsieh YH; Lin HJ; Tseng GY; Perng CL; Wang K; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(55):316-9. PubMed ID: 15011893
[TBL] [Abstract][Full Text] [Related]
23. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.
Robinson M; Rodriguez-Stanley S; Ciociola AA; Filinto J; Zubaidi S; Miner PB; Gardner JD
Dig Dis Sci; 2002 Feb; 47(2):265-73. PubMed ID: 11855540
[TBL] [Abstract][Full Text] [Related]
24. The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring.
Udd M; Töyry J; Miettinen P; Vanninen E; Mustonen H; Julkunen R
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1351-6. PubMed ID: 16292089
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric ph-metry in duodenal ulcer hemorrhage].
Artal A; Lanas A; Barrao ME; Moliner FJ; Blas JM; López J
Rev Esp Enferm Dig; 1996 Mar; 88(3):191-6. PubMed ID: 8645512
[TBL] [Abstract][Full Text] [Related]
26. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Omari TI; Haslam RR; Lundborg P; Davidson GP
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
[TBL] [Abstract][Full Text] [Related]
27. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
[TBL] [Abstract][Full Text] [Related]
28. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
29. Increased hepatocyte growth factor content in rat stomach during omeprazole treatment.
Kinoshita Y; Hassan MS; Kawamura M; Matsushima Y; Okada A; Maekawa T; Fukui H; Waki S; Kishi K; Chiba T
Digestion; 1998; 59(2):102-9. PubMed ID: 9586821
[TBL] [Abstract][Full Text] [Related]
30. Use of Point-of-Care Gastric pH Testing to Assess the Efficacy of Acid Suppression Therapy in the Neonatal Intensive Care Unit.
Ekhaguere OA; Padula MA; Jensen EA
Am J Perinatol; 2020 Mar; 37(4):415-420. PubMed ID: 30780184
[TBL] [Abstract][Full Text] [Related]
31. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
32. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
[TBL] [Abstract][Full Text] [Related]
33. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
34. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients.
Conrad SA; Gabrielli A; Margolis B; Quartin A; Hata JS; Frank WO; Bagin RG; Rock JA; Hepburn B; Laine L
Crit Care Med; 2005 Apr; 33(4):760-5. PubMed ID: 15818102
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage.
Phillips JO; Metzler MH; Palmieri MT; Huckfeldt RE; Dahl NG
Crit Care Med; 1996 Nov; 24(11):1793-800. PubMed ID: 8917027
[TBL] [Abstract][Full Text] [Related]
37. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
38. [Omeprazol and ezomeprazol pharmacokinetics, duration of antisecretory effect, and reasons for their probable changes in duodenal ulcer].
Serebrova SIu; Starodubtsev AK; Pisarev VV; Kondratenko SN; Vasilenko GF; Dobrovol'skiĭ OV
Eksp Klin Gastroenterol; 2009; (4):86-92. PubMed ID: 19960999
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
Thomson AB; Keelan M; Lastiwka R; Appelman-Eszczuk S; Zuk L; Drozdowski L; Prentice A; Sinclair P
Dig Dis Sci; 2003 Oct; 48(10):2045-56. PubMed ID: 14627354
[TBL] [Abstract][Full Text] [Related]
40. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
